Genitourinary Cancer,Other Cancers Association of imAEs With Outcomes in mUC Treated With Durvalumab With or Without Tremelimumab May 15, 2023
Genitourinary Cancer,Other Cancers Rogaratinib Versus Chemotherapy for Metastatic Urothelial Carcinoma: FORT-1 Study May 15, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab With Vibostolimab/Favezelimab for High-Risk BCG-Unresponsive NMIBC Patients May 15, 2023
Genitourinary Cancer,Other Cancers First-Line Pembrolizumab With or Without Chemotherapy for Advanced Urothelial Carcinoma May 15, 2023
Lung Cancer,Other Cancers A Phase 3 Study on Serplulimab Plus Chemo for First-Line ES-SCLC May 15, 2023
Lung Cancer,Other Cancers Pembrolizumab With Pemetrexed-Platinum for Metastatic Non-squamous NSCLC May 15, 2023
Lung Cancer,Other Cancers Biosimilar CT-P16 Versus Reference Bevacizumab in Metastatic NSCLC May 15, 2023
Lung Cancer,Other Cancers Tumor Mutational Burden and Tislelizumab + Chemo in Advanced NSQ-NSCLC May 15, 2023
